Resistant hypertension and obstructive sleep apnea: The sparring partners

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Thomopoulos, Costas ^a   Michalopoulou, Helena ^b   Kasiakogias, Alexandros ^c   Kefala, Anna ^c   Makris, Thomas ^a  

^a HELENA VENIZELOU HOSPITAL   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; LEPTIN; SODIUM;

AGE; ALDOSTERONE BLOOD LEVEL; ARTERIAL STIFFNESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; OBESITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REM SLEEP; RESISTANT HYPERTENSION; REVIEW; SEX; SLEEP DISORDERED BREATHING; SLEEP TIME; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 84863471181     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/947246     Document Type: Review

References (37)

1. Lavie P., Herer P., Hoffstein V., Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. British Medical Journal 2000 320 7233 479 482 2-s2.0-0034685268 (Pubitemid 30173118)
2. Javier Nieto F., Young T. B., Lind B. K., Shahar E., Samet J. M., Redline S., D'Agostino R. B., Newman A. B., Lebowitz M. D., Pickering T. G., Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study. Journal of the American Medical Association 2000 283 14 1829 1836 2-s2.0-0343362699 (Pubitemid 30207619)
3. Friedman O., Logan A. G., The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. American Journal of Hypertension 2009 22 5 474 483 2-s2.0-67349217380 10.1038/ajh.2009.43
4. Tsioufis C., Kasiakogias A., Thomopoulos C., Manolis A., Stefanadis C., Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy. Journal of Hypertension 2010 28 5 875 882 2-s2.0-77951266289 10.1097/HJH.0b013e328336ed85
5. Tsioufis C., Thomopoulos C., Stefanadis C., Obstructive sleep apnoea and hypertension: a growing clinical challenge. Hellenic Journal of Cardiology 2008 49 5 299 302 2-s2.0-57349113007
6. Goodfriend T. L., Obesity, sleep apnea, aldosterone, and hypertension. Current Hypertension Reports 2008 10 3 222 226 2-s2.0-56349123806 10.1007/s11906-008-0042-x
7. Garrison R. J., Kannel W. B., Stokes J., Castelli W. P., Incidence and precursors of hypertension in young adults: the Framingham offspring study. Preventive Medicine 1987 16 2 235 251 2-s2.0-0023204243 (Pubitemid 17067798)
8. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0038460302 10.1001/jama.289.19.2560 (Pubitemid 37430158)
9. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A. M., Kjeldsen S. E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R. E., Boudier H. A. J. S., Zanchetti A., 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. Journal of Hypertension 2007 25 9 1751 1762 2-s2.0-34548383480 10.1097/HJH.0b013e3282f0580f (Pubitemid 47356612)
10. Marrone O., Lombardi C., Parati G., gianfranco.parati@unimib.it Effects of continuous positive airway pressure therapy on hypertension control in patients with sleep-related breathing disorders: available evidence and unresolved issues. Journal of Hypertension 2010 28 10 2012 2015 10.1097/HJH.0b013e32833f0e7e
11. Rexrode K. M., Manson J. E., Hennekens C. H., Obesity and cardiovascular disease. Current Opinion in Cardiology 1996 11 5 490 495 2-s2.0-0029767984 (Pubitemid 26320988)
12. Bramlage P., Pittrow D., Wittchen H. U., Kirch W., Boehler S., Lehnert H., Hoefler M., Unger T., Sharma A. M., Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. American Journal of Hypertension 2004 17 10 904 910 2-s2.0-5544244681 10.1016/j.amjhyper.2004.05.017 (Pubitemid 39366016)
13. Cushman W. C., William.Cushman@med.va.gov Ford C. E., Cutler J. A., Margolis K. L., Davis B. R., Grimm R. H., Black H. R., Hamilton B. P., Holland J., Nwachuku C., Papademetriou V., Probstfield J., Wright Jr. J. T., Alderman M. H., Weiss R. J., Piller L., Bettencourt J., Walsh S. M., Success and predictors of blood pressure control in diverse North American settings: te antihypertensive and lipid-lowering treatment to prevent heart attact trial (ALLHAT). Journal of Clinical Hypertension 2002 4 6 393 404 (Pubitemid 35469393)
14. Haynes W. G., Role of leptin in obesity-related hypertension. Experimental Physiology 2005 90 5 683 688 2-s2.0-26044452059 10.1113/expphysiol.2005.031237 (Pubitemid 41406056)
15. Tümer N., Erdös B., Matheny M., Cudykier I., Scarpace P. J., Leptin antagonist reverses hypertension caused by leptin overexpression, but fails to normalize obesity-related hypertension. Journal of Hypertension 2007 25 12 2471 2478 2-s2.0-35848935007 10.1097/HJH.0b013e3282e9a9fd (Pubitemid 350060386)
16. Thomopoulos C., Papadopoulos D. P., Papazachou O., Bratsas A., Massias S., Anastasiadis G., Perrea D., Makris T., Free leptin is associated with masked hypertension in nonobese subjects a cross-sectional study. Hypertension 2009 53 6 965 972 2-s2.0-67049100067 10.1161/HYPERTENSIONAHA.108.128041
17. Schäfer H., Pauleit D., Sudhop T., Gouni-Berthold I., Ewig S., Berthold H. K., Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002 122 3 829 839 2-s2.0-0036384408 10.1378/chest.122.3.829
18. Hall J. E., The kidney, hypertension, and obesity. Hypertension 2003 41 3 625 633 2-s2.0-0037340168 10.1161/01.HYP.0000052314.95497.78 (Pubitemid 36314565)
19. Tsioufis C., Thomopoulos C., Dimitriadis K., Amfilochiou A., Tsiachris D., Selima M., Petras D., Kallikazaros I., Stefanadis C., Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. American Journal of Kidney Diseases 2008 52 2 285 293 2-s2.0-47149094110 10.1053/j.ajkd.2008.05.001 (Pubitemid 351978143)
20. Damman K., van Deursen V. M., Navis G., Voors A. A., van Veldhuisen D. J., Hillege H. L., Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. Journal of the American College of Cardiology 2009 53 7 582 588 2-s2.0-59649087169 10.1016/j.jacc.2008.08.080
21. Goodfriend T. L., Calhoun D. A., Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004 43 3 518 524 2-s2.0-1442338287 10.1161/01.HYP.0000116223.97436.e5 (Pubitemid 38282420)
22. Calhoun D. A., Nishizaka M. K., Zaman M. A., Harding S. M., Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004 125 1 112 117 2-s2.0-1442307014 10.1378/chest.125.1.112 (Pubitemid 38114572)
23. Tsioufis C., Thomopoulos K., Dimitriadis K., Amfilochiou A., Tousoulis D., Alchanatis M., Stefanadis C., Kallikazaros I., The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. Journal of Hypertension 2007 25 1 141 146 2-s2.0-33845351680 10.1097/HJH.0b013e32801092c1 (Pubitemid 44885675)
24. Dimsdale J. E., Coy T., Ziegler M. G., Ancoli-Israel S., Clausen J., The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995 18 5 377 381 2-s2.0-0029056033
25. Thomopoulos C., Tsioufis C., Dimitriadis K., Tsiachris D., Tousoulis D., Manolis A., Alchanatis M., Kallikazaros I., Stefanadis C., Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. Journal of Human Hypertension 2009 23 1 65 67 2-s2.0-57749201168 10.1038/jhh.2008.101
26. Logan A. G., Perlikowski S. M., Mente A., Tisler A., Tkacova R., Niroumand M., Leung R. S. T., Bradley T. D., High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. Journal of Hypertension 2001 19 12 2271 2277 2-s2.0-0035215206 10.1097/00004872-200112000-00022 (Pubitemid 33135251)
27. Ruttanaumpawan P., Nopmaneejumruslers C., Logan A. G., Lazarescu A., Qian I., Bradley T. D., Association between refractory hypertension and obstructive sleep apnea. Journal of Hypertension 2009 27 7 1439 1445 2-s2.0-67649766449 10.1097/HJH.0b013e32832af679
28. Gonçalves S. C., Martinez D., Gus M., De Abreu-Silva E. O., Bertoluci C., Dutra I., Branchi T., Moreira L. B., Fuchs S. C., De Oliveira A. C. T., Fuchs F. D., Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007 132 6 1858 1862 2-s2.0-37549018512 10.1378/chest.07-1170
29. Martínez-García M. A., Gómez-Aldaraví R., Gil-Martínez T., Soler-Cataluña J. J., Bernácer-Alpera B., Román-Sánchez P., Sleep-disordered breathing in patients with difficult-to-control hypertension. Archivos de Bronconeumologia 2006 42 1 14 20 2-s2.0-32844465977 10.1157/13083275 (Pubitemid 43253807)
30. Pratt-Ubunama M. N., Nishizaka M. K., Boedefeld R. L., Cofield S. S., Harding S. M., Calhoun D. A., Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007 131 2 453 459 2-s2.0-33847193562 10.1378/chest.06-1442
31. Logan A. G., Tkacova R., Perlikowski S. M., Leung R. S., Tisler A., Floras J. S., Bradley T. D., Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. European Respiratory Journal 2003 21 2 241 247 2-s2.0-12244252795 10.1183/09031936.03.00035402 (Pubitemid 36204537)
32. Martínez-García M. A., Gómez-Aldaraví R., Soler-Cataluña J. J., Martínez T. G., Bernácer-Alpera B., Román-Sánchez P., Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. European Respiratory Journal 2007 29 5 951 957 2-s2.0-34248174802 10.1183/09031936.00048606 (Pubitemid 46711900)
33. Lozano L., Tovar J. L., Sampol G., Romero O., Jurado M., Segarra A., Espinel E., Ríos J., Untoria M. D., Lloberes P., Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. Journal of Hypertension 2010 28 2161 2168 2-s2.0-77953845206 10.1097/HJH.0b013e32833b9c63
34. Dernaika T. A., Kinasewitz G. T., Tawk M. M., Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. Journal of Clinical Sleep Medicine 2009 5 2 103 107 2-s2.0-65349120772
35. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., Merino-Sanchez M., Gonzalez-Benitez M. A., Beltran-Robles M., Almeida-Gonzalez C., Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006 129 6 1459 1467 2-s2.0-33745120484 10.1378/chest.129.6.1459 (Pubitemid 43894973)
36. Campos-Rodriguez F., Perez-Ronchel J., Grilo-Reina A., Lima-Alvarez J., Benitez M. A., Almeida-Gonzalez C., Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 2007 132 6 1847 1852 2-s2.0-37549061417 10.1378/chest.07-1478
37. Gaddam K., Pimenta E., Thomas S. J., Cofield S. S., Oparil S., Harding S. M., Calhoun D. A., Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. Journal of Human Hypertension 2009 24 532 537 2-s2.0-72049115551 10.1038/jhh.2009.96